Drugs that contain Telbivudine

1. Drug name - TYZEKA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7858594 NOVARTIS Crystalline and amorphous forms of beta-L-2′-deoxythymidine
Sep, 2023

(11 months from now)

US7589079 NOVARTIS Crystalline and amorphous forms of beta-L-2′-deoxythymidine
Sep, 2023

(11 months from now)

CN1714098A NOVARTIS L-2 ' - Deoxythymidine Of Crystallized And Amorphous
Aug, 2023

(10 months from now)

CN100376593C NOVARTIS L-2 ' - Deoxythymidine Of Crystallized And Amorphous
Aug, 2023

(10 months from now)

EP1534727B1 NOVARTIS Pharmaceutical Compositions Of Crystalline Beta-L-2'-Deoxythymidine
Aug, 2023

(10 months from now)

EP1534727A4 NOVARTIS Crystalline And Amorphous Forms Of Beta-L-2 -Deoxythymidine
Aug, 2023

(10 months from now)

EP1534727A2 NOVARTIS Pharmaceutical Compositions Of Crystalline Beta-L-2'-Deoxythymidine
Aug, 2023

(10 months from now)

Treatment: NA

Dosage: SOLUTION;ORAL

More Information on Dosage
Strength Dosage Availability
100MG/5ML SOLUTION;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.